Latest filing published 18 Jan 2022 for C4 Therapeutics, Inc., €12k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Malcolm Salter is a declared insider of C4 Therapeutics, Inc. (board member), with filings sourced from SEC (Form 4). In total, 11 filings cover trades dated from 21 May 2021 to 4 January 2022.
No open-market purchase appears, only 8 sales worth €205k. Besides market trades, the filings include 3 share grants.
The newest entry dates from 18 January 2022: a share grant of €12k, in C4 Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations